FeaturesSignalPricingFounders
Log inGet started free
JL

Jafco Life Science

Venture CapitalModerate

Jafco Life Science is a venture capital firm specialized in early and late stage venture investments.

Tokyo, JapanFounded 2017
6
Investments
6
Exits
$3.5B
AUM
100.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Jafco Life Science.

Get started free

Investment Thesis & Strategy

Jafco Life Science invests in both early and late-stage companies across various industries, seeking to support ventures with significant growth potential.

Notable Exits

CompanyTypeYearValue / Acquirer
Abeona TherapeuticsIPO2015
Kura OncologyIPO2015
Fate TherapeuticsIPO2013
Portola PharmaceuticalsIPO2013
XencorIPO2013
Seattle GeneticsIPO2001

Frequently Asked Questions

Jafco Life Science focuses on Series A, Series B, Series C+ stage investments.

Related Investors